New Insights Rifamycin B Biosynthesis : Isolation of Proansamycin B and 34a-Deoxy-rifamycin W as Early Macrocyclic Intermediates Indicating Two Separated Biosynthetic Pathways

Search this Article

Author(s)

    • STRATMANN Ansgar
    • Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
    • SCHUPP Thomas
    • Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
    • TOUPET Christiane
    • Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
    • OBERER Lukas
    • Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
    • TRABER Rene
    • Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies

Journal

  • J. Antibiot.

    J. Antibiot. 55(4), 396-406, 2002-04-25

References:  20

Cited by:  1

Codes

  • NII Article ID (NAID)
    10008472526
  • NII NACSIS-CAT ID (NCID)
    AA0069330X
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    00218820
  • Data Source
    CJP  CJPref 
Page Top